MDS 2026 – Advancing clinical research in movement disorders
Roche at MDS 2026 | Seoul | October 4 – 8, 2026
Join Roche at MDS 2026 to explore new research and approaches to measuring disease progression in movement disorders.
Overview
Clinical research in movement disorders requires sensitive and meaningful ways to understand change over time. At MDS 2026, Roche will share research exploring how digital measures can complement traditional assessments and provide new insights into disease progression.
Explore frequent, objective measures that can complement periodic clinical assessments.
Discover new research in Parkinson's disease presented by Roche scientists.
Access case studies, research and deeper evidence on the campaign page.
Scientific highlights
Two Roche presentations at MDS 2026 highlight new approaches to remote measurement in Parkinson's disease.
1:00-2:00 PM KST
Research on consistent remote measurement of turn speed across body locations.
9:30-10:30 AM KST
Longitudinal digital measurement of motor progression across medication states.
See how digital measures are designed to complement traditional clinical assessments in Parkinson's disease research, giving trial teams frequent, objective insight into the participant and site experience between visits.
Explore published research and scientific evidence supporting digital measurement in clinical trials.
See how digital measures have been used across Parkinson's disease and other clinical research programs.
Learn more about approaches designed to support study participants and clinical trial sites.

Visit Roche at the 2026 International Congress of Parkinson's Disease and Movement Disorders and meet our team. Find us at Booth #208, COEX Convention and Exhibition Center, Seoul.